Form 4 for ULBI ULTRALIFE CORP
Accepted 2024-04-19 00:00:00 ET · period of report 2024-04-17 · accession 0001437749-24-012544 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-19 | 2024-04-17 | ULBI | FAIN PHILIP A | CFO, Treas | M - OptEx | $5.71 | +7,179 | 137.8K | +5% | +$41.0K |
| D | 2024-04-19 | 2024-04-17 | ULBI | FAIN PHILIP A | CFO, Treas | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock; $.10 par value | 2024-04-17 | M | A | 7,179 | $5.71 | 137,809 | D | — | — | (F1) (1) Represents shares of common stock acquired by the Reporting Person upon exercise of options for 20,000 shares of common stock of the Company, net of 12,821 shares of common stock, retained by the Company at a price determined pursuant to the terms of the Company's 2014 Long Term Incentive Plan, in payment of the exercise price for the options. |
| 2 | Derivative | Stock Options | 2024-04-17 | M | D | 20,000 | $0.00 | 0 | D | $5.71 · 2024-04-17 to 2024-04-19 | 20,000 Common Stock | (F2) (2) Represents exercise of options for 20,000 shares of common stock of the Company. |